Brca2 Mutation Testing

BRCA2 Mutation Testing is a molecular diagnostic assay that identifies pathogenic germline variants in the BRCA2 gene, distinguishing it from other genetic tests by its specific focus on mutations associated with hereditary breast and ovarian cancer susceptibility.

335

Publications

21.9K

Citations

2.3K

Authors

735

Institutions

Publications per year

2017–2026

89

Authors

2.3K

  1. SA
    Steven A. Narod

    University of Toronto, Canada

    24 publications · 1.8K citations

    18

    h-index

  2. DG
    D. Gareth Evans

    University of Manchester, United Kingdom

    12 publications · 813 citations

    12

    h-index

  3. KM
    Kelly Metcalfe

    University of Toronto, Canada

    9 publications · 752 citations

    9

    h-index

  4. JL
    John L. Hopper

    The University of Melbourne, Australia

    8 publications · 792 citations

    8

    h-index

  5. TP
    Tuya Pal

    Moffitt Cancer Center, United States

    7 publications · 437 citations

    7

    h-index

1–5 of 2.3K

Venues

  1. Journal of Clinical Oncology

    16 publications · 2.6K citations

    16

    h-index

  2. PubMed

    Repository · 18 publications · 1.7K citations

    15

    h-index

  3. Breast Cancer Research and Treatment

    18 publications · 868 citations

    15

    h-index

  4. Clinical Genetics

    13 publications · 413 citations

    13

    h-index

  5. British Journal of Cancer

    BJC · 10 publications · 1.2K citations

    11

    h-index

1–5